Clinical SupplementPowered by HealixAI • HSA/FSA Eligible

Clinical Multi-Strain Probiotic

Delayed-release clinical probiotic with clinically studied Lactobacillus, Bifidobacterium, and Saccharomyces strains

Clinically Reviewed by HealixAI Board-Certified Physicians•Gastroenterology & Microbiome Formulary•HCPCS / Code: LMN-213D
HealixAIPowered by HealixAI • Physician-Formulated
HSA / FSA Eligible • Save ~30%
Clinical Multi-Strain Probiotic (50 Billion CFU)Enlarge1/2 Views
Enlarge Studio View
Medical Dispensary

Clinical Multi-Strain Probiotic (50 Billion CFU)

Chart Indication: K58.9 (Irritable bowel syndrome without diarrhea)

Acid-resistant Lactobacillus, Bifidobacterium, and Saccharomyces strains dosed 2 hours apart from antibiotics to protect mucosal flora.

$41.00$54.00~$28.70 w/ HSA·FSA
In Stock • Direct Dispatch via Medical Dispensary
Compare stores:
Qualifying Health Goals (HSA/FSA)
  • Irritable bowel syndrome without diarrhea
  • Irritable bowel syndrome with diarrhea
  • Constipation, unspecified
  • Noninfective gastroenteritis and colitis, unspecified
Clinical Guidance & Safety

AGA Clinical Practice Guidelines on Probiotics — Acid-resistant Lactobacillus & Bifidobacterium strains for post-antibiotic & IBS gut restoration.

Want dosing & safety tailored to your lab results and medications?

Sync your health records or ask Healix Medical Intelligence by voice on this page.